{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-015239","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.843535+00:00","generated_at":"2026-05-16T03:07:05.900837+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"60 Degrees Pharmaceuticals regains Nasdaq compliance on minimum bid price; delisting hearing cancelled","bullets":["Received Nasdaq notice on Feb 11 confirming compliance with minimum bid price rule 5550(a)(2).","Prior delisting notice from Jan 20, 2026 was appealed and stayed pending hearing.","Hearing scheduled for Feb 19, 2026 has been cancelled; matter closed.","Company's common stock and warrants continue trading on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-015239","json":"https://secwatch.observer/filing/0001213900-26-015239.json","markdown":"https://secwatch.observer/filing/0001213900-26-015239.md","text":"https://secwatch.observer/filing/0001213900-26-015239.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026015239/0001213900-26-015239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026015239/ea0276747-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:07:05.900837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}